• 1
    Petty RE, Southwood TR, Manners P, Baum J, Glass DN, Goldenberg J, et al. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol 2004; 31: 3902.
  • 2
    Hofer M, Southwood TR. Classification of childhood arthritis. Best Pract Res Clin Rheumatol 2002; 16: 37996.
  • 3
    Weiss JE, Ilowite NT. Juvenile idiopathic arthritis. Pediatr Clin North Am 2005; 52: 41342.
  • 4
    Prince FH, Otten MH, van Suijlekom-Smit LW. Diagnosis and management of juvenile idiopathic arthritis. BMJ 2010; 341: c6434.
  • 5
    Ferguson PJ, El-Shanti HI. Autoinflammatory bone disorders. Curr Opin Rheumatol 2007; 19: 4928.
  • 6
    Khanna G, Sato TS, Ferguson P. Imaging of chronic recurrent multifocal osteomyelitis. Radiographics 2009; 29: 115977.
  • 7
    El-Shanti HI, Ferguson PJ. Chronic recurrent multifocal osteomyelitis: a concise review and genetic update. Clin Orthop Relat Res 2007; 462: 119.
  • 8
    Bjorksten B, Boquist L. Histopathological aspects of chronic recurrent multifocal osteomyelitis. J Bone Joint Surg Br 1980; 62: 37680.
  • 9
    Unkila-Kallio L, Kallio MJ, Eskola J, Peltola H. Serum C-reactive protein, erythrocyte sedimentation rate, and white blood cell count in acute hematogenous osteomyelitis of children. Pediatrics 1994; 93: 5962.
  • 10
    Martinez-Aguilar G, Avalos-Mishaan A, Hulten K, Hammerman W, Mason EO Jr, Kaplan SL. Community-acquired, methicillin-resistant and methicillin-susceptible Staphylococcus aureus musculoskeletal infections in children. Pediatr Infect Dis J 2004; 23: 7016.
  • 11
    Vohra R, Kang HS, Dogra S, Saggar RR, Sharma R. Tuberculous osteomyelitis. J Bone Joint Surg Br 1997; 79: 5626.
  • 12
    Jaramillo D, Treves ST, Kasser JR, Harper M, Sundel R, Laor T. Osteomyelitis and septic arthritis in children: appropriate use of imaging to guide treatment. AJR Am J Roentgenol 1995; 165: 399403.
  • 13
    Duszynski DO, Kuhn JP, Afshani E, Riddlesberger MM Jr. Early radionuclide diagnosis of acute osteomyelitis. Radiology 1975; 117: 33740.
  • 14
    Mazur JM, Ross G, Cummings J, Hahn GA Jr, McCluskey WP. Usefulness of magnetic resonance imaging for the diagnosis of acute musculoskeletal infections in children. J Pediatr Orthop 1995; 15: 1447.
  • 15
    Krogsdad P. Osteomyelitis. In: Cherry J, Kaplan SL, Demmler-Harrison GJ, Steinbach WJ, editors. Textbook of pediatric infectious diseases. Philadelphia: WB Saunders; 2010. p. 725.
  • 16
    Cabral DA, Tucker LB. Malignancies in children who initially present with rheumatic complaints. J Pediatr 1999; 134: 537.
  • 17
    Jonsson OG, Sartain P, Ducore JM, Buchanan GR. Bone pain as an initial symptom of childhood acute lymphoblastic leukemia: association with nearly normal hematologic indexes. J Pediatr 1990; 117: 2337.
  • 18
    Ostrov BE, Goldsmith DP, Athreya BH. Differentiation of systemic juvenile rheumatoid arthritis from acute leukemia near the onset of disease. J Pediatr 1993; 122: 5958.
  • 19
    Trapani S, Grisolia F, Simonini G, Calabri GB, Falcini F. Incidence of occult cancer in children presenting with musculoskeletal symptoms: a 10-year survey in a pediatric rheumatology unit. Semin Arthritis Rheum 2000; 29: 34859.
  • 20
    Kilburn LB, Siegel SE, Steuber CP. Clinical assessment and differential diagnosis of the child with suspected cancer. In: Pizzo PA, Poplack DG, editors. Principles and practice of pediatric oncology. Philadelphia: Lippincott Williams & Wilkins; 2011. p. 12337.
  • 21
    Jones OY, Spencer CH, Bowyer SL, Dent PB, Gottlieb BS, Rabinovich CE. A multicenter case-control study on predictive factors distinguishing childhood leukemia from juvenile rheumatoid arthritis. Pediatrics 2006; 117: e8404.
  • 22
    Sinigaglia R, Gigante C, Bisinella G, Varotto S, Zanesco L, Turra S. Musculoskeletal manifestations in pediatric acute leukemia. J Pediatr Orthop 2008; 28: 208.
  • 23
    Abraham N, Carty R, DuFour D, Pincus M. Clinical enzymology. In: McPherson RA, Pincus MR, editors. Henry's clinical diagnosis and management by laboratory methods. 21st ed. Philadelphia: W. B. Saunders; 2006. p. 3402.
  • 24
    Lee YT, Van Peenen HJ, Watson FR. Chemical and hematological screening in patients with malignant and non-malignant conditions. J Surg Oncol 1980; 15: 4351.
  • 25
    Margolin JF, Rabin KR, Steuber P, Poplack DG. Acute lymphoblastic leukemia. In: Pizzo PA, Poplack DG, editors. Principles and practice of pediatric oncology. Philadelphia: Lippincott Williams and Wilkins; 2011. p. 51865.
  • 26
    McLean TW, Wofford MM. Oncology assessment, principles of cancer treatment, leukemia, lymphoma, central nervous system tumors, neuroblastoma, Wilms' tumor, and sarcomas. In: Marcdante KJ, Kliegman RM, Jenson HB, Behrman RE, editors. Nelson essentials of pediatrics. 6th ed. Philadelphia: Saunders; 2011: p. 585606.
  • 27
    Sutcliffe MJ, Shuster JJ, Sather HN, Camitta BM, Pullen J, Schultz KR, et al. High concordance from independent studies by the Children's Cancer Group (CCG) and Pediatric Oncology Group (POG) associating favorable prognosis with combined trisomies 4, 10, and 17 in children with NCI standard-risk B-precursor acute lymphoblastic leukemia: a Children's Oncology Group (COG) initiative. Leukemia 2005; 19: 73440.
  • 28
    Smith M, Arthur D, Camitta B, Carroll AJ, Crist W, Gaynon P, et al. Uniform approach to risk classification and treatment of children with acute lymphoblastic leukemia. J Clin Oncol 1996; 14: 1824.
  • 29
    Children's Oncology Group web site.
  • 30
    Borowitz MJ, Devidas M, Hunger SP, Bowman WP, Carroll AJ, Carroll WL, et al. Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia and its relationship to other prognostic factors: a Children's Oncology Group study. Blood 2008; 111: 547785.
  • 31
    Blatt J, Penchansky L, Horn M. Thrombocytosis as a presenting feature of acute lymphoblastic leukemia in childhood. Am J Hematol 1989; 31: 469.
  • 32
    Revesz T, Kardos G, Kajtar P, Schuler D. The adverse effect of prolonged prednisolone pretreatment in children with acute lymphoblastic leukemia. Cancer 1985; 55: 163740.
  • 33
    Pui CH, Evans WE. Treatment of acute lymphoblastic leukemia. N Engl J Med 2006; 354: 16678.